cbdMD, INC. — Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR

Next earnings (estimated): Wed, April 1, 2026 29 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-12-31$5M↓-1.9%$-283K↓-1975.7%-5.7%
2025-09-30$5M↑+3.6%
2025-06-30$5M↓-11.0%$-895K↓-294.7%-19.6%
2025-03-31$5M↑+8.5%$-481K↑+84.0%-10.2%
2024-12-31$5M↓-4.9%$15K↑+101.5%-1.7%
2024-09-30$5M↓-20.2%$-153K↑+99.0%
2024-06-30$5M↓-15.5%$460K↑+126.0%-7.4%
2024-03-31$4M↓-29.9%$-3M↓-125.2%-35.4%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q4)

Revenue
$5M
↓-1.9% -$97K YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 37 quarters

margin trajectory tells the operating-leverage story
Gross Margin↓-6.7pts
59.8%
Operating Margin↓-4.0pts
-5.7%
Net Margin↓-5.9pts
-5.6%

Go deeper